Agentic AI Framework Speeds Health Economic Model Conceptualization in the U.S.

An agentic artificial intelligence framework using GPT-5.2 and graph retrieval accelerates health economic decision model conceptualization, reducing development time from months to days while maintaining expert-validated accuracy.

Visualization of AI conceptualizing health economic decision models using graph retrieval and chain-of-thought reasoning

Agentic AI in Health Economics

Part 1 of 1

1
Agentic AI Framework Speeds Health Economic Model Conceptualization in the U.S.

Table of Contents

    Health economic decision models, essential for evaluating cost-effectiveness of healthcare interventions and informing policy and reimbursement, traditionally require extensive multidisciplinary collaboration and months of work to conceptualize. Researchers have developed an agentic artificial intelligence (AI) framework that integrates OpenAI GPT-5.2 with a relational graph database encoding clinical guidelines and health technology assessment knowledge to expedite this process.

    This hybrid intelligence system employs chain-of-thought prompting, self-consistency techniques, and human-in-the-loop validation, positioning AI as an active reasoning partner capable of proposing clinical pathways and identifying structural inconsistencies under expert supervision. The framework’s use of Microsoft GraphRAG enables retrieval-augmented generation from domain-specific, interconnected knowledge graphs rather than isolated documents.

    Proof-of-concept studies in advanced breast cancer and hereditary transthyretin amyloid polyneuropathy demonstrated that the AI-generated model architectures closely matched expert appraisals, while reducing conceptualization time from up to three months to approximately one hour of automated processing, extending to one to two days with expert validation. The system recommended clinically justifiable cohort Markov models tailored to each disease context, enhancing transparency and structural granularity.

    While the approach shows promising efficiency gains and improved transparency for health economic model development, further expert consensus, regulatory compliance, and integration of patient-level data are necessary before clinical adoption. The study was published in PharmacoEconomics – Open (2026) by Srivastava et al., highlighting a significant advancement in applying generative AI to healthcare analytics.

    Source

    Share this article

    Related Posts